The Periodontal Problems and Management of the Renal Transplant Patient

References

• Page R. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 1991; 26: 230–242
   PubMed Web of Science ®Google Scholar
• Been V, Engel D. The effects of immunosuppressive drugs on periodontal inflammation in human renal allograft patients. J Periodontol 1982; 53: 245–248
   Google Scholar
• Oshrain H I, Telsey B, Mandel L D. A longitudinal study of periodontal disease in patients with reduced immunocapacity. J Periodontol 1983; 54: 151–154
   Google Scholar
• Sutton R BO, Smales F C. Cross-sectional study of the effects of immunosuppressive drugs on chronic periodontal disease in man. J Clin Periodontol 1983; 10: 317–326
   Google Scholar
• Tollefsen T, Johansen J R. The periodontal status of prospective and renal transplant patients: comparison with systemically healthy patients. J Periodont Res 1985; 20: 220–226
   Google Scholar
• Schuller P D, Freedman H L, Lewis D W. Periodontal status of renal transplant patients receiving immunosuppressive therapy. J Periodontol 1973; 44: 167–170
   PubMed Web of Science ®Google Scholar
• Dobbelstein H. Immune system in uraemia. Nephron 1976; 17: 409–414
   PubMed Web of Science ®Google Scholar
• Rebuck J W, LeSher D A, Perkins M J, Leal F. Leucocyte response as a monitor of immunosuppression in man. Immunopathology of Inflammation, B K Forscher, J C Houck. Excerpta Medica, Amsterdam 1971; 132–157
   Google Scholar
• Tollefsen T, Saltvedt E, Koppang H S. The effect of immunosuppressive agents on periodontal disease in man. J Periodont Res 1978; 13: 240–250
   Google Scholar
• Tollefsen T, Johansen J R. Periodontal status before and after renal allotransplantation. J Periodont Res 1985; 20: 227–236
   PubMed Web of Science ®Google Scholar
• Eigner T L, Jastak J T, Bennett W M. Achieving oral health in patients with renal failure and renal transplants. J Am Dent Assoc 1986; 113: 612–616
   PubMed Web of Science ®Google Scholar
• Sowell S B. Dental care for patients with renal failure and renal transplants. J Am Dent Assoc 1982; 104: 171–177
   Google Scholar
• Wilson R L, Martinez-Tiraddo J, Whelchel J, Lordodn R E. Occult dental infections causing fever in renal transplant patients. Am J Kidney Dis 1982; 2: 354–356
   PubMedGoogle Scholar
• Reyna M, Richardson J M, Mattox D E, Banowsky L H, Judith J, Nicastro-Lutton R N. Head and neck infection after renal transplantation. J Am Med Assoc 1982; 247: 3337–3339
   Google Scholar
• Epstein S R, Mandel I, Scopp I W. Salivary composition and calculus formation in patients undergoing haemodialysis. J Periodontol 1980; 51: 336–337
   PubMed Web of Science ®Google Scholar
• Rateitschak-Pluss E M, Hefti A, Lortscher R. Initial observations that cyclosporin A induces gingival enlargement in man. J Clin Periodontol 1983; 10: 237–246
   PubMedGoogle Scholar
• Freehally J, Walls J, Mistry N. Does nifedipine ameliorate cyclosporin A nephrotoxicity. Br Med J 1987; 295: 310
   Google Scholar
• Seymour R A. Calcium channel blockers and gingival overgrowth. Br Dent J 1991; 170: 376–380
   Google Scholar
• Thomason J M, Seymour R A, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993; 20: 37–40
   PubMedGoogle Scholar
• Hassell T M, Hefti A F. Drug-induced gingival overgrowth: old problem, new problem. Crit Rev Oral Biol Med 1991; 2: 103–137
   PubMedGoogle Scholar
• Daley T D, Wysocki G P, May C. Clinical and pharmacological correlations in cyclosporin-induced gingival hyperplasia. Oral Surg 1986; 62: 417–421
   Google Scholar
• Seymour R A, Smith D G, Rogers S R. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. J Clin Periodontol 1987; 14: 610–613
   Google Scholar
• McGaw T, Lam S, Coates J. Cyclosporin-induced gingival overgrowth: correlation with dental plaque scores, gingivitis scores and cyclosporin levels in serum and saliva. Oral Surg 1987; 48: 293–297
   Google Scholar
• Schultz A, Lange D, Hassell T M. Ciclosporin-induzierte gingivahyperplalsie bei patienten mit Nierentrans-plantaten. Dtsch Z Zeitschr 1990; 45: 414–416
   Google Scholar
• Phillips B, Shen S, Lesko L. Levels of cyclosporin-A in human parotid fluid and whole saliva. J Dent Res 1986; 65: 353
   Google Scholar
• Tyldesley W R, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984; 157: 305–309
   PubMedGoogle Scholar
• Seymour R A, Smith D G. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991; 18: 107–110
   PubMed Web of Science ®Google Scholar
• Yahia N, Seibel W, McCleary L. Effect of tooth brushing on cyclosporin-induced gingival overgrowth in beagles. J Dent Res 1988; 67: 332
   Google Scholar
• Rostock M H, Fry H R, Turner J E. Severe gingival overgrowth associated with cyclosporin therapy. J Periodontol 1986; 56: 294–299
   Google Scholar
• Coley C, Jarvis K, Hassell T. Effects of cyclosporin-A on human gingival fibroblasts. J Dent Res 1986; 65: 353
   Google Scholar
• Zebrowski E J, Singer D L, Brunka J R. Cyclosporin-A, nifedipine and phenytoin: comparative effects on gingival fibroblast metabolism. J Dent Res 1986; 65: 331
   Google Scholar
• Dental Practitioner's Formulary 1990–1992. Pharmaceutical Press, London
   Google Scholar
• Thomason J M, Seymour R A, Kelly P J. Risk factors in cyclosporin-induced gingival overgrowth, Submitted for publication
   Google Scholar
• Daly C G. Resolution of cyclosporin-induced gingival enlargement following reduction of cyclosporin dosage. J Clin Periodontol 1992; 19: 143–145
   Google Scholar
• Daley T D, Wysocki G P, Day C. Clinical and pharmacologic correlations in cyclosporin-induced gingival hyperplasia. Oral Surg 1986; 62: 417–421
   Google Scholar
• King G N, Fullinfaw R, Higgins T S, Walker R J, Francis D MA, Wiesenfeld D. Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. J Clin Periodontol 1993; 20: 286–293
   Google Scholar
• Stone C, Eshenaur A, Hassell T. Gingival enlargement in cyclosporin treated multiple sclerosis patients. J Dent Res 1989; 68: 285
   Google Scholar
• Thomason J M, Seymour R A, Soames J V. Severe mucosal hyperplasia of the edentulous maxilla associated with immunosuppressant therapy: a clinical report. J Pros Dent 1994; 72: 1–3
   Google Scholar
• Zlotogorski A, Nyska M, Sela M, Nyska A, Gotsman M. Nifedipine-induced gingival hyperplasia: case reports and literature review. Israel J Med Sci 1989; 25: 453–455
   Google Scholar
• Kardachi B JR, Newcomb G M. A clinical study of gingival inflammation in renal transplant patients taking immunosuppressive drugs. J Periodontol 1978; 49: 307–309
   Google Scholar
• Oshrain H I, Mender S, Mandel I D. Periodontal status of patients with reduced immunocapacity. J Periodontol 1979; 50: 185–188
   Google Scholar
• Wysocki G P, Gretzinger H A, Laupacis A, Ulan R A, Stiller C R. Fibrous hyperplasia of the gingiva: a side effect of cyclosporin-A therapy. Oral Surg 1983; 55: 274–278
   Google Scholar
• Bennett J A, Christian J M. Cyclosporin-induced gingival hyperplasia: case report and literature review. J Am Dent Assoc 1985; 111: 272–273
   Google Scholar
• Friskopp J, Klintmalm G. Gingival enlargement—a comparison between cyclosporine and azathioprine treated renal-allograft recipients. Swed Dent J 1986; 10: 85–92
   Google Scholar
• Slavin J, Taylor J. Cyclosporin, nifedipine, and gingival hyperplasia. Lancet 1987; ii: 739
   Google Scholar
• Bartold P M. Cyclosporin and gingival overgrowth. J Oral Pathol 1987; 16: 464–468
   Google Scholar